PPARG and metabolic disease: Inflammasomes interact with various metabolic regulatory pathways, including the mechanistic target of rapamycin (mTOR) and peroxisome proliferator-activated receptor gamma (PPARγ), highlighting the complexity of their roles in metabolic disorders.